Dr. Wahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 NE Neff Rd
Bend, OR 97701Phone+1 541-706-5800Fax+1 415-353-9883
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 2015 - 2019
- University of California (San Francisco)Residency, Radiation Oncology, 2013 - 2017
- Scripps Mercy HospitalInternship, Transitional Year, 2012 - 2013
- University of California San Francisco School of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2013 - Present
- OR State Medical License 2017 - 2025
- CO State Medical License 2003 - 2017
- FL State Medical License 1992 - 2017
- IL State Medical License 1993 - 2017
- PA State Medical License 1995 - 2016
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 32 citationsProbing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.Michael Wahl, Susan M. Chang, Joanna J. Phillips, Annette M. Molinaro, Joseph F. Costello
Cancer. 2017-12-01 - 51 citationsTemozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.Yao Yu, Javier Villanueva-Meyer, Matthew R. Grimmer, Stephanie Hilz, David A. Solomon
Neuro-Oncology. 2021-11-02 - 120 citationsTemozolomide-associated hypermutation in gliomas.Serah Choi, Yao Yu, Matthew R. Grimmer, Michael Wahl, Susan M. Chang
Neuro-Oncology. 2018-09-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: